{"date":"2026-09-24","count":17,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6574-2026-09-24-1935-17439io","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2026-09-24","time":"19:35:32","subject":"公告本公司最近一年累積處分有價證券達公告標準(補充115/09/23公告)","clause":"第20款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2026-09-24 19:35，「公告本公司最近一年累積處分有價證券達公告標準(補充115/09/23公告)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6472-2026-09-24-1925-c97c1e","company_id":"6472","company":"保瑞","market":"上市","industry":"生技醫療","date":"2026-09-24","time":"19:25:02","subject":"代重要子公司保盛藥業股份有限公司公告處分不動產(補充說明115年9月7日公告)","clause":"第20款","fact_date":"2026-09-24","cite_as":"公開資訊觀測站重大訊息：保瑞（6472），2026-09-24 19:25，「代重要子公司保盛藥業股份有限公司公告處分不動產(補充說明115年9月7日公告)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-09-24-1724-10apgwn","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-09-24","time":"17:24:25","subject":"公告本公司股票初次上市前現金增資認股繳款期間暨暫定承銷價相關事宜","clause":"第44款","fact_date":"2026-09-24","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-09-24 17:24，「公告本公司股票初次上市前現金增資認股繳款期間暨暫定承銷價相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2026-09-24-1621-ff0uku","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2026-09-24","time":"16:21:56","subject":"代重要子公司欣德芮(股)公司公告除權息基準日","clause":"第14款","fact_date":"2026-09-24","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2026-09-24 16:21，「代重要子公司欣德芮(股)公司公告除權息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-09-24-1617-19xrvud","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-09-24","time":"16:17:44","subject":"公告本公司國內第一次有擔保轉換公司債代收價款行庫及存儲專戶行庫","clause":"第53款","fact_date":"2026-09-24","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-09-24 16:17，「公告本公司國內第一次有擔保轉換公司債代收價款行庫及存儲專戶行庫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-09-24-1606-1vz0chc","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-09-24","time":"16:06:31","subject":"公告本公司董事會決議部分放棄參與子公司御華生醫股份有限公司之現金增資","clause":"第44款","fact_date":"2026-09-24","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-09-24 16:06，「公告本公司董事會決議部分放棄參與子公司御華生醫股份有限公司之現金增資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-09-24-1603-1ay1aod","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-09-24","time":"16:03:49","subject":"本公司說明勞資爭議調解有關訊息","clause":"第51款","fact_date":"2026-09-24","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-09-24 16:03，「本公司說明勞資爭議調解有關訊息」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-09-24-1600-6jzuzr","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-09-24","time":"16:00:54","subject":"公告本公司董事會決議參與子公司御華生醫股份有限公司115年第一次現金增資","clause":"第17款","fact_date":"2026-09-24","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-09-24 16:00，「公告本公司董事會決議參與子公司御華生醫股份有限公司115年第一次現金增資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2026-09-24-1600-etova2","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2026-09-24","time":"16:00:16","subject":"本公司研發之預防性細菌性疫苗(簡稱:CHO-V08)，接獲臨床試驗受託研究機構(CRO)完成之第一期人體臨床試驗期中分析報告。","clause":"第44款","fact_date":"2026-09-24","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2026-09-24 16:00，「本公司研發之預防性細菌性疫苗(簡稱:CHO-V08)，接獲臨床試驗受託研究機構(CRO)完成之第一期人體臨床試驗期中分析」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-09-24-1556-9acjsf","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-09-24","time":"15:56:40","subject":"依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款規定公告","clause":"第22款","fact_date":"2026-09-24","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-09-24 15:56，「依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-09-24-1536-1v89vf8","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-09-24","time":"15:36:06","subject":"公告本公司買回庫藏股期間屆滿執行情形","clause":"第35款","fact_date":"2026-09-28","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-09-24 15:36，「公告本公司買回庫藏股期間屆滿執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2026-09-24-1529-bbt91z","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2026-09-24","time":"15:29:07","subject":"公告本公司財務主管、會計主管、公司治理主管及代理發言人異動(新任者簡歷更正)","clause":"第8款","fact_date":"2026-09-24","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2026-09-24 15:29，「公告本公司財務主管、會計主管、公司治理主管及代理發言人異動(新任者簡歷更正)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-09-24-1528-ytgfom","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-09-24","time":"15:28:42","subject":"代子公司御華生醫股份有限公司公告115年第一次現金增資發行新股認股基準日相關事宜","clause":"第9款","fact_date":"2026-09-24","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-09-24 15:28，「代子公司御華生醫股份有限公司公告115年第一次現金增資發行新股認股基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-09-24-1527-p67uuk","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-09-24","time":"15:27:13","subject":"公告本公司內部稽核主管異動","clause":"第11款","fact_date":"2026-09-24","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-09-24 15:27，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2026-09-24-1439-t3bsot","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2026-09-24","time":"14:39:11","subject":"公告本公司財務主管、會計主管、公司治理主管及代理發言人異動","clause":"第8款","fact_date":"2026-09-24","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2026-09-24 14:39，「公告本公司財務主管、會計主管、公司治理主管及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-09-24-1358-10xp8ea","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-09-24","time":"13:58:34","subject":"公告本公司董事會決議更換股務代理機構","clause":"第53款","fact_date":"2026-09-24","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-09-24 13:58，「公告本公司董事會決議更換股務代理機構」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-09-24-1356-bodjf1","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-09-24","time":"13:56:15","subject":"公告本公司董事會決議自115年第3季起更換簽證會計師","clause":"第7款","fact_date":"2026-09-24","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-09-24 13:56，「公告本公司董事會決議自115年第3季起更換簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}